Google
IART Stock Analysis — INTEGRA LIFESCIENCES HOLDINGS (Healthcare >> Medical Devices)
IART FAQ
What is IART's P/E ratio?
INTEGRA LIFESCIENCES HOLDINGS (IART) currently trades at a P/E ratio of 479.29.
What is IART's ROE?
INTEGRA LIFESCIENCES HOLDINGS reports a Return on Equity (ROE) of -0.69%.
What is IART's dividend yield?
INTEGRA LIFESCIENCES HOLDINGS offers a dividend yield of 0.00%.
What is IART's Quality Score?
Our AI rates IART's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy IART?
Our AI Timing Score for IART is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does IART belong to?
INTEGRA LIFESCIENCES HOLDINGS is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
IART AI Analysis Summary
Our AI summary for IART: INTEGRA LIFESCIENCES HOLDINGS (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 479.29, ROE of -0.69%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 69/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 16.65
Price
-0.47
(-2.75%)
Day Change
|
|
|---|
IART, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 16.65 |
| PBV / Sector |
1.27 / -101.57
GOOD
|
| Earning Per Share | -0.09 |
| PE / Sector |
479.29 / 31.23
|
| PEG or PE/Growth / Sector |
0.20 / 0.40
GREAT
|
| Average 1M Daily Value |
18.58 M
GREAT
|
| Average 1W Daily Value |
25.74 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 07:59:59 |
| Symbol | IART |
| Name | INTEGRA LIFESCIENCES HOLDINGS |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 77.77 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,331.47 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1100 Campus Road, Princeton, NJ, United States, 08540
Phone: 609 275 0500
Website: https://www.integralife.com
Employees: 4,427
Sector: Healthcare >> Medical Devices
Description: Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
